ResMed Inc (RMD)

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology...

Form 144 - Report of proposed sale of securities

Form SD - Specialized disclosure report

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell...

Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology...

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor 

SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology...

Form 8-K - Current report

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026

Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis GAAP gross margin up 290 bps to...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors